SEARCH

SEARCH BY CITATION

References

  • 1
    Morrow GR: Management of nausea in the cancer patient, in RosenthalS, CarignanJR, SmithBD (eds): Medical Care of the Cancer Patient. Philadelphia, WB Saunders Company, 1987, pp 381388.
  • 2
    Harris JG: Nausea, vomiting and cancer treatment. CA 28: 194201, 1978.
  • 3
    Durant JR: The problem of nausea and vomiting in modern cancer chemotherapy. CA 34: 26, 1984.
  • 4
    Krakoff IH: Cancer chemotherapeutic agents. CA 37: 93105, 1987.
  • 5
    Hoagland AC, Morrow GR, Bennett JM, Carnrike CLM Jr: Oncologists' views of cancer patient noncompliance. Am J Clin Oncol 6: 239244, 1983.
  • 6
    Stuart-Harris R, Simes RJ, Coates AS, et al: Patient treatment preference in advanced breast cancer: A randomized cross-over study of doxorubicin and mitozantrone. Eur J Cancer Clin Oncol 23: 557561, 1987.
  • 7
    Olver IN, Simon RM, Aisner J: Antiemetic studies: A methodological discussion. Cancer Treat Rep 70: 555563, 1986.
  • 8
    DavisCJ, Lake-BakaarGV, Grahame-SmithDG (eds): Nausea and Vomiting: Mechanisms and Treatment. Berlin, Springer-Verlag, 1986.
  • 9
    Laszlo J: Antiemetics and Cancer Chemotherapy. Baltimore, Williams and Wilkins, 1983.
  • 10
    Borison HL, Wang SC: Physiology and pharmacology of vomiting. Pharmacol Rev 5: 193230, 1953.
  • 11
    Borison HL, Borison R, McCarthy LE: Role of the area postrema in vomiting and related functions. Federation Proceedings 43: 29552958, 1984.
  • 12
    Borison HL, McCarthy LE: Neuropharmacology of chemotherapy-induced emesis. Drugs 25: 817, 1983.
  • 13
    Peroutka SJ, Snyder SH: Antiemetics: Neurotransmitter receptor binding predicts therapeutic actions. Lancet 1: 658659, 1982.
  • 14
    Harris AL: Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet 1: 714716, 1982.
  • 15
    Kobrinsky NL, Pruden PB, Cheang MS, et al: Increased nausea and vomiting induced by naloxone in patients receiving cancer chemotherapy. Ped Res 21: 300A, 1987.
  • 16
    Seigel LJ, Longo DL: The control of chemotherapy induced emesis. Ann Intern Med 95: 352359, 1981.
  • 17
    Gralla RJ, Tyson LB, Kris MG, Clark RA: The management of chemotherapy-induced nausea and vomiting. Med Clin North Am 71: 289301, 1987.
  • 18
    D'Acquisto RW, Tyson LB, Gralla RJ, et al: The influence of a chronic high alcohol intake on chemotherapy-induced nausea and vomiting. Proc Am Soc Clin Oncol 5: 257, 1986.
  • 19
    Sullivan JR, Leyden MJ, Bell R: Decreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion. N Engl J Med 309: 796, 1983.
  • 20
    Morrow GR: Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy. Cancer Treat Rep 68: 11771178, 1984.
  • 21
    Morrow GR: The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 55: 27662770, 1985.
  • 22
    Gralla RJ, Braun TJ, Squillante A, et al : Metoclopramide: Initial clinical studies of high dosage regimens in cisplatin-induced emesis, in PosterD (ed): The Treatment of Nausea and Vomiting Induced by Cancer Chemotherapy. New York, Masson Publishing, 1981, pp 167176.
  • 23
    Morrow GR: Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. J Clin Oncol 2: 11701176, 1984.
  • 24
    Fetting JH, Wilcox PM, Iwata BA, et al: Anticipatory nausea and vomiting in a medical oncology clinic. Proc Am Soc Clin Oncol 2: 62, 1983.
  • 25
    Kris MG, Tyson LB, Gralla RJ, et al: Extrapyramidal reactions with high-dose metoclopramide. N Engl J Med 309: 433434, 1983.
  • 26
    Allen JC, Gralla RJ, Reilly L, et al: Metoclopramide: Dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 3: 11361141, 1985.
  • 27
    Morrow GR, Morrell C: Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med 307: 14761480, 1982.
  • 28
    Morrow GR: Effect of the cognitive hierarchy in the systematic desensitization treatment of anticipatory nausea in cancer patients: A component comparison with relaxation only, counseling and no treatment. Cognitive Therapy and Research 10: 421446, 1986.
  • 29
    Cassileth BR, Lusk EJ, Bodenheimer BJ, et al: Chemotherapeutic toxicity: The relationship between patients' pretreatment expectations and posttreatment results. Am J Clin Oncol 8: 419425, 1985.
  • 30
    Ettinger DS: The clinical use of antiemetics, in DerogatisLR (ed): Clinical Psychopharmacology. Redding, Mass, Addison Wesley, Inc, 1986, pp 248268.
  • 31
    Gralla RJ, Tyson LB, Bordin LA, et al: Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol. Cancer Treat Rep 68: 163172, 1984.
  • 32
    Carey MP, Burish TG, Brenner DE: Delta-9-tetrahydrocannabinol in cancer chemotherapy: Research problems and issues. Ann Intern Med 99: 106114, 1983.
  • 33
    Vincent BJ, McQuiston DJ, Einhorn LH, et al: Review of cannabinoids and their antiemetic effectiveness. Drugs 25: 5262, 1983.
  • 34
    Wampler G: The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Drugs 25 (suppl 1): 3551, 1983.
  • 35
    Morrow GR: Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients. JNCI 68: 585588, 1982.
  • 36
    Burish TG, Carey MP, Redd WH, Krozely MG: Efficacy of behavioral relaxation techniques in reducing the distress of cancer chemotherapy patients. Oncol Nurs Forum 10: 3235, 1983.
  • 37
    Redd WH, Andrykowski MA: Behavioral intervention in cancer treatment: Controlling aversion reactions to chemotherapy. J Consult and Clin Psychol 50: 10181029, 1982.
  • 38
    Morrow GR: Behavioral management of chemotherapy-induced nausea and vomiting in the cancer patient. The Clinical Oncologist 1: 3, 11–14, 1986.
  • 39
    Morrow GR, Dobkin PL: Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: Prevalence, etiology, and behavioral interventions. Clin Psych Rev 8: 517556, 1988.